CALA - Calithera Biosciences Stock Trading

SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a fully-integrated clinical-stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening disease...

Calithera Biosciences Inc. (NASDAQ:CALA) traded today at a new 52-week low of $1.78. This new low was reached on approximately average trading volume as 760,000 shares traded hands, while the average 30-day volume is approximately 1 million shares. There is potential upside of 14.2% for ...

Shares of Calithera Biosciences Inc. (NASDAQ:CALA) traded today at $1.86, breaking its 52-week low. This new low was reached on approximately average trading volume as 760,000 shares traded hands, while the average 30-day volume is approximately 1.1 million shares. Calithera Biosciences ...